Liquidia Corporation (LQDA)
NASDAQ·Healthcare·Biotechnology
$37.60
+0.70%
Mkt Cap $3.29B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $88.59M | $92.02M | +3.88% | $0.08 | $0.15 | +87.50% | — | — |
| Q4 2025 Nov 3, 2025 | $80.72M | $54.34M | -32.68% | -$0.45 | -$0.04 | +91.11% | — | — |
| Q3 2025 Aug 12, 2025 | $14.30M | $8.84M | -38.20% | -$0.43 | -$0.49 | -13.95% | — | — |
| Q2 2025 May 8, 2025 | $4.16M | $3.12M | -25.02% | -$0.42 | -$0.45 | -7.14% | — | — |
| Q1 2025 Mar 19, 2025 | $3.31M | $2.92M | -11.99% | -$0.38 | -$0.46 | -21.05% | — | — |
| Q4 2024 Nov 13, 2024 | $4.63M | $4.45M | -4.01% | -$0.37 | -$0.37 | +0.00% | — | — |
| Q3 2024 Aug 7, 2024 | $9.45M | $3.66M | -61.28% | -$0.35 | -$0.37 | -5.71% | — | — |
| Q2 2024 May 13, 2024 | $4.47M | $2.97M | -33.58% | -$0.32 | -$0.54 | -68.75% | — | — |
| Q1 2024 Mar 13, 2024 | $4.73M | $4.53M | -4.21% | -$0.23 | -$0.42 | -82.61% | — | — |
| Q4 2023 Nov 7, 2023 | $4.79M | $3.68M | -23.22% | -$0.20 | -$0.24 | -20.00% | — | — |
| Q3 2023 Aug 10, 2023 | $4.32M | $4.79M | +10.91% | -$0.17 | -$0.36 | -111.76% | — | — |
| Q2 2023 May 4, 2023 | $3.95M | $4.49M | +13.82% | -$0.18 | -$0.18 | +0.00% | — | — |
| Q1 2023 Mar 16, 2023 | $3.55M | $5.36M | +50.84% | -$0.17 | -$0.09 | +47.06% | — | — |
| Q4 2022 Nov 8, 2022 | $3.76M | $3.17M | -15.83% | -$0.18 | -$0.14 | +22.22% | — | — |
| Q3 2022 Aug 11, 2022 | $3.59M | $3.92M | +9.18% | -$0.24 | -$0.15 | +37.50% | — | — |
| Q2 2022 May 12, 2022 | $3.30M | $3.49M | +5.95% | -$0.20 | -$0.30 | -50.00% | — | — |
| Q1 2022 Mar 17, 2022 | $3.05M | $3.22M | +5.54% | -$0.11 | -$0.23 | -109.09% | — | — |
| Q4 2021 Nov 3, 2021 | $4.33M | $3.18M | -26.59% | -$0.12 | -$0.14 | -16.67% | — | — |
| Q3 2021 Aug 10, 2021 | $3.38M | $3.38M | +0.00% | -$0.16 | -$0.13 | +18.75% | — | — |
| Q2 2021 May 13, 2021 | $3.08M | $3.08M | +0.00% | -$0.20 | -$0.21 | -5.00% | — | — |